Cargando…
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
Studies over the past decades have uncovered fusion genes, a class of oncogenes that provide immense diagnostic and therapeutic advantages because of their tumor-specific expression. Originally associated with hemotologic cancers, fusion genes have recently been discovered in a wide array of solid t...
Autores principales: | Parker, Brittany C., Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845546/ https://www.ncbi.nlm.nih.gov/pubmed/24206917 http://dx.doi.org/10.5732/cjc.013.10178 |
Ejemplares similares
-
Expert consensus on the diagnosis and treatment of
NTRK
gene fusion solid tumors in China
por: Xu, Chunwei, et al.
Publicado: (2022) -
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy
por: Ross, Jeffrey S., et al.
Publicado: (2016) -
Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
por: Petaccia de Macedo, Mariana, et al.
Publicado: (2023) -
Integrins regulate stemness in solid tumor: an emerging therapeutic target
por: Xiong, Jiangling, et al.
Publicado: (2021) -
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
por: Luo, Dandan, et al.
Publicado: (2016)